When was TearLab founded?

TearLab was founded in 2003 and raised its 1st funding round 6 years after it was founded.

Where is TearLab located?

TearLab is headquartered in San Diego, United States.

How many employees does TearLab have?

As of Jul 01, 2024, the latest employee count at TearLab is 261.

Is TearLab a funded company?

TearLab is a funded company, having raised an undisclosed amount across 7 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Sep 10, 2009.

When was the latest funding round of TearLab?

TearLab's latest funding was a $***** Post IPO round on Oct 08, 2015, with participation from 0 investor. Its primary sector is Ophthalmology. In United States, the Ophthalmology sector has seen $601M in funding in 2026 to date.

What is the annual revenue of TearLab?

Annual revenue of TearLab is $22.7M as on Dec 31, 2019.

Where does TearLab rank among its competitors?

TearLab ranks 3rd amongst 46 active competitors, of which 9 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Big Vision, which secured $4.15M in May, 2024.

Who are the top competitors of TearLab?

TearLab's top competitors include Toku Eyes, Pr3vent and Cassini. Among them, Big Vision secured the most recent funding round in May, 2024.

TearLab - 2026 Company Profile, Team, Funding, Competitors & Financials

TearLab is an acquired company based in San Diego (United States), founded in 2003. It operates as a Developer of diagnostic tests for detecting hyperosmolarity. TearLab has raised an undisclosed amount in funding. The company has 46 active competitors, including 9 funded and 5 that have exited. Its top competitors include companies like Toku Eyes, Pr3vent and Cassini.

Company Details

TearLab develops diagnostics for hyperosmolarty. The company offers the TearLab Osmolarity Test for revealing tear film osmolarity (a sign of dry eye disease) by testing for disease markers in tears. The test is done using its proprietary TearLab point-of-care instrument.

Website: tearlab.com
Social
Email ID: *****@TearLab.com

Key Metrics

Founded Year

2003

Location

San Diego, United States

Stage

Acquired

Latest Funding Round

Post IPO, Oct 08, 2015, $*****

Investors

CRG & 1 more

Ranked

3^rd among 46 active competitors

Annual Revenue

$22.7M as on Dec 31, 2019

Employee Count

261 as on Jul 01, 2024

Investment & Acquisitions

OcuHub

Similar Companies

Toku Eyes & 61 more

Exit Details

Acquired by Accelmed (May 11, 2020)

View TearLab's full profile

TearLab is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
TEARLAB CORP CIN: 1299139 , United States, Active	Jun 04, 2002	$22.7M (As on Dec 31, 2019)	-	-

TearLab got acquired by Accelmed on May 11, 2020.

Click here to take a look at TearLab's acquisition in detail

TearLab has raised funding over 7 rounds. Its first funding round was on Sep 10, 2009. TearLab has 2 institutional investors.

Here is the list of recent funding rounds of TearLab:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 08, 2015	9319963	Post IPO	5525282	5133877	3592477	4488280
Mar 05, 2015	9164631	Conventional Debt	4041234	8614718	4317483	CRG
Jul 06, 2011	3716026	Post IPO	7698387	9697672	1280547	8934810

Access funding benchmarks and valuations. Sign up today!

View details of TearLab's funding rounds and investors

TearLab's employee count trend

TearLab has 261 employees as of Jul 24. Here is TearLab's employee count trend over the years:

Uncover TearLab's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of TearLab include Toku Eyes, Pr3vent and Cassini. Here is the list of Top 10 competitors of TearLab, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Toku Eyes 2018, Auckland (New Zealand), Acquired	Developer of AI-powered retinal image analysis for early disease detection. This company offers tools that analyze retinal images to identify indicators of various health conditions, including cardiovascular risk and chronic kidney disease. The technology utilizes artificial intelligence to provide non-invasive, real-time assessments, potentially enabling earlier diagnosis and intervention. The company's products are subject to varying regulatory approvals depending on the region.	$10.5M	National Vision, Icehouse Ventures & 16 others	56/100
2nd	Pr3vent 2017, San Francisco (United States), Series A	Provider of AI-based platform for ophthalmic conditions in newborns	$2.5M	Trousdale Ventures, InFocus Capital Partners ... & 1 others	43/100
3rd	TearLab 2003, San Diego (United States), Acquired	Developer of diagnostic tests for detecting hyperosmolarity	-	CRG, Greybrook	40/100
4th	Cassini 2006, The Hague (Netherlands), Series A	Provider of corneal diagnostic solutions	$547K	IPF Partners, Innovation Industries	39/100
5th	Quantel Medical 1993, Cournon (France), Series C	Ultrasound and Laser devices for opthalmology	$13.7M	-	39/100
6th	Escalon Medical 1987, Wayne (United States), Public	Ophthalmic medical device company specializing in diagnostics, imaging, and surgical solutions	-	-	38/100
7th	Shanggong Medical Letter 2014, Beijing (China), Series A	Provider of fundus screening and chronic disease management	$7.32M	DM Capital, Korea Investment Partners & 3 others	37/100
8th	Octlight 2014, Lyngby (Denmark), Seed	Provider of non-invasive medical imaging light sources for eye diagnosis	$1.44M	Syddansk Innovation, EIC Fund & 4 others	36/100
9th	BioLight 2005, Tel Aviv (Israel), Public	Diagnostics and therapeutics for ophthalmology	-	-	36/100
10th	Big Vision 2015, Suzhou (China), Series A	Provider of ophthalmology diagnosis and analysis systems	$8.52M	SND Ventures Group, Kunshan High-tech Venture Capital ... & 1 others	36/100